Bristol-Myers Squibb (BMY) Announces FDA Accepts Applications for Opdivo + Yervoy and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic ESCC

Go back to Bristol-Myers Squibb (BMY) Announces FDA Accepts Applications for Opdivo + Yervoy and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic ESCC
Bristol-Myers Squibb (NYSE: BMY) Delayed: 54.64 -1.89 (3.34%)
Previous Close $56.53    52 Week High $77.12 
Open $55.84    52 Week Low $49.03 
Day High $56.30    P/E 35.48 
Day Low $54.60    EPS $1.54 
Volume 22,028,046